SS Innovations International (SSII) said Monday that its SSi Mantra 3 surgical robotic system was used successfully to perform robotic cardiac surgery.
The company said the surgery involved a robotic Atrial Septal Defect closure, which is a procedure that repairs a hole between the two upper chambers of the heart.
SS Innovations also said it was the first time the robotic system had been used in the Americas and Western Hemisphere.
Shares of the company were up 5% in recent trading.
Price: 3.70, Change: +0.16, Percent Change: +4.52
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.